- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
19 Schizophrenia Trials near Chicago, IL
Power is an online platform that helps thousands of Schizophrenia patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerKarXT for Schizophrenia
Trial Details
Key Eligibility Criteria
280 Participants Needed
SEP-363856 for Schizophrenia
Trial Details
Key Eligibility Criteria
522 Participants Needed
Digital Therapeutics for Schizophrenia
Trial Details
Key Eligibility Criteria
432 Participants Needed
OLZ/SAM vs. Olanzapine for Schizophrenia or Bipolar Disorder
Trial Details
Key Eligibility Criteria
220 Participants Needed
OLZ/SAM for Schizophrenia
Trial Details
Key Eligibility Criteria
236 Participants Needed
Clozapine vs Risperidone for Psychosis
Trial Details
Key Eligibility Criteria
524 Participants Needed
Emraclidine for Schizophrenia
Trial Details
Key Eligibility Criteria
850 Participants Needed
ALTO-101 for Schizophrenia
Trial Details
Key Eligibility Criteria
82 Participants Needed
Coordinated Specialty Care for Psychosis
Trial Details
Key Eligibility Criteria
180 Participants Needed
KarXT for Schizophrenia
Trial Details
Key Eligibility Criteria
360 Participants Needed
Long-term Safety of Iclepertin for Schizophrenia
Trial Details
Key Eligibility Criteria
1361 Participants Needed
SEP-363856 for Schizophrenia
Trial Details
Key Eligibility Criteria
67 Participants Needed
TV-44749 for Schizophrenia
Trial Details
Key Eligibility Criteria
675 Participants Needed
Cariprazine for Pediatric Schizophrenia
Trial Details
Key Eligibility Criteria
310 Participants Needed
Valbenazine for Schizophrenia
Trial Details
Key Eligibility Criteria
442 Participants Needed
LB-102 for Schizophrenia
Trial Details
Key Eligibility Criteria
350 Participants Needed
Brilaroxazine for Schizophrenia
Trial Details
Key Eligibility Criteria
690 Participants Needed
Dexmedetomidine for Agitation in Schizophrenia and Bipolar Disorder
Trial Details
Key Eligibility Criteria
450 Participants Needed
ABBV-932 for Generalized Anxiety Disorder
Trial Details
Key Eligibility Criteria
72 Participants Needed
Why Other Patients Applied
"I've tried lots of drugs and I still have symptoms. I'm not sure of my reality because the things I see and hear are still active. Maybe this will help one way or the other. I would be glad to help others in the future by testing a medication as well."
"I’ve been diagnosed with Schizoaffective Disorder for over 5 years now and not found much relief in medication. One I’ve tried helped a bit but the side affects were overwhelming. Hoping I can gain some relief from this disorder and help advance research as well!"
"My psychosis has been manageable for the past few years since I found an antipsychotic that works okay but I still struggle with a lot of mind fog and memory issues. I haven't heard of a treatment for those symptoms until learning about new research so I'm hoping to join a trial to get access."
"I would like to get a medication that has fewer side effects than the ones I've used. Many antipsychotics just make me numb or flat and I can't really think. Also I like the idea of helping in research to find better medications for schizephrenia."
"I really would love to be normal. A functioning part of society. It is very hard to hold a job with this condition. I need to be steady. I do NOT like my current meds or ones I've tried before, so new therapies are of interest to me. "
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Schizophrenia clinical trials in Chicago, IL pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Schizophrenia clinical trials in Chicago, IL work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Schizophrenia trials in Chicago, IL 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length in Chicago, IL for Schizophrenia is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility in Chicago, IL several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Schizophrenia medical study in Chicago, IL?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Schizophrenia clinical trials in Chicago, IL?
Most recently, we added SEP-363856 for Schizophrenia, ALTO-101 for Schizophrenia and LB-102 for Schizophrenia to the Power online platform.